AMGN vs CRVL · P/E 24, rev $10.05B vs P/E 29, rev $958.5M
Amgen Inc (AMGN) versus CorVel Corp (CRVL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
CorVel Corp (CRVL) is a insurance brokers company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CRVL revenue for 2026-03-31 was $958.5M. Net income was $110.3M. Revenue was up 7.0% from 2025-03-31 to 2026-03-31. CRVL currently screens at market cap $3.13B and trailing P/E 28.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CRVL currently screens at market cap $3.13B and trailing P/E 28.9.
Not investment advice. Open the AMGN and CRVL stock pages for the full models.
Not investment advice.